ALKN-401

N/A

Report date: 2025/01/03 16:39:21

Base Information

Drug NameALKN-401
Drug Alias NameALKN-401ALKN401
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsImmunoglobulin G4-Related Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShanghai Allink Biotherapeutics Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Allink Biotherapeutics Co Ltd
Inactive CompaniesN/A
Active IndicationsImmunoglobulin G4-Related Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A